Insulin and Endothelin in the Acute Regulation of Adiponectin in Vivo in Humans

Abstract

BRAME, LORI A., ROBERT V. CONSIDINE, MIKAKO YAMAUCHI, ALAIN D. BARON, AND KIEREN J. MATHER. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans. Obes Res. 2005;13:582-588. Objective: In vitro, insulin and endothelin (ET) both modulate adiponectin secretion from adipocyte cell lines. The current studies were performed to assess whether endogenous ET contributes to the acute action of insulin infusions on adiponectin levels in vivo in humans. Research Methods and Procedures:We studied 17 lean and 20 obese subjects (BMI 21.8 Ϯ 2.2 and 34.0 Ϯ 5.0 kg/m 2 , respectively). Hyperinsulinemic euglycemic clamp studies were performed using insulin infusion rates of 10, 30, or 300 mU/m 2 per minute alone or with concurrent infusion of BQ123, an antagonist of type A ET receptors. Circulating adiponectin levels were assessed at baseline and after achievement of steady-state glucose with the insulin infusion. Results: Adiponectin levels were lower in obese than lean subjects (6.76 Ϯ 3.66 vs. 8.37 Ϯ 2.79 g/mL, p ϭ 0.0148 adjusted for differences across gender). Insulin infusions suppressed adiponectin by a mean of 7.8% (p Ͻ 0.0001). In a subset of 13 lean and 14 obese subjects for whom data with and without BQ123 were available, there was no evident effect of BQ123 to modulate clamp-associated suppression of adiponectin (p ϭ 0.16). Surprisingly, there was no evident relationship between steady-state insulin concentrations and adiponectin suppression (r ϭ 0.14, p ϭ 0.30), and again no effect of BQ123 to modify this relationship was seen.Discussion: Despite baseline differences in adiponectin levels, we observed equal suppression of adiponectin with insulin infusions in lean and obese subjects. ET receptor antagonism with BQ123 did not modulate this effect, suggesting that endogenous ET does not have a role in modifying the acute effects of insulin on adiponectin production and/or disposition.

Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease

“…In hyperinsulinemic euglycemic clamp studies, in fact, insulin infusion provoked a prolonged inhibition on adiponectin gene expression and circulating levels in lean and obese subjects. 42,43 Our patients consumed a diet richer in saturated and poorer in polyunsaturated fat compared with controls, and PUFA intake independently predicted fasting adiponectin levels. Available data show that the amount and type of dietary fat regulate adiponectin secretion by acting on nuclear sterol regulatory element-binding protein 1c 44 : a 3-day low-fat diet increased circulating adiponectin without affecting insulin levels or insulin sensitivity in diabetic patients.…”

Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism

“…Differences statistically significant compared to non-pregnant with p<0.001 ISI Insulin sensitivity index, HGP hepatic glucose production a Pregnant vs pregravid tion of plasma adiponectin. Total adiponectin, as well as HMW multimers, decrease in response to insulin infusion [6,35,36], but this may be regulated at the level of secretion rather than transcription [37]. Adiponectin is secreted as HMW and LMW multimeric complexes, and the amount of circulating complexes is likely to be regulated at the tissue level because LMW and HMW complexes do not interchange in the serum [38].…”

Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans

“…Since hyperinsulinemia and hyperglycemia are characteristic biochemical features of these patients, insulin as well as glucose could be responsible for the downregulation of adiponectin. Insulin's inhibiting effect on adiponectin gene expression and plasma levels has been shown in several in vitro and in vivo studies (8,11,37). However, additional factors must be involved, because in the more advanced stages of type 2 diabetes, associated with decreased plasma insulin levels, adiponectin concentrations remain low (17).…”